Showing 11-20 of 797 results for "".
The Ketogenic Diet: Overcoming Challenges for Optimal Utilization in Epilepsy Treatment
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-ketogenic-diet-overcoming-challenges-for-optimal-utilization-in-epilepsy-treatment/30318/Despite current logistical and clinical challenges, dietary therapy will play a significant role in epilepsy treatment for years to come.Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/traumatic-brain-injury/31246/David Brody, MD, PhD, Chief Science Officer, Center for Neuroscience and Regenerative Medicine, Uniformed Services University of the Health Sciences, provides a comprehensive overview of TBI, including sports-related concussion, TBI in various populations, and common sequelae, including mood disorde- Medicare: Take the 2008 Model for a Test Drivehttps://practicalneurology.com/columns/practice-management/medicare-take-the-2008-model-for-a-test-drive/31091/Medicare Payment Revisions and CMS Updates Impacting Neurological Practices in 2008In the November 2007 issue of *Practical Neurology*, Craig T. Williams outlines significant changes introduced by the Centers for Medicare & Medicaid Services (CMS) that are set to affect neurological practices in
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31144/Participating in clinical trials presents a valuable opportunity for neurology practices to expand services and enhance revenue streams. Clinical trials are integral to the drug development process, enabling the pharmaceutical industry to assess the safety and efficacy of new neurological treatments
NMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-3-overview-of-treatment-including-goals-triggers-and-considerations-for-switching-therapies/30089/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podNMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-2-the-importance-and-tools-for-monitoring-nmosd-and-signs-symptoms-and-evaluation-of-disease-activity/30088/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podNMOSD Part 1 - Overview and important considerations for diagnosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-1-overview-and-important-considerations-for-diagnosis/30086/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podDietary Therapy in Genetic Epilepsies
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/dietary-therapy-in-genetic-epilepsies/32054/The ketogenic diet has been used to achieve remission from seizures in a variety of drug-resistant genetic epilepsies.Dietary Treatments for Patients with Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/dietary-treatments-for-patients-with-epilepsy/30181/Ketogenic diets are an effective treatment when used properly with medical supervision and support.Dietary Therapies for Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/dietary-therapies-for-epilepsy/30490/Dietary therapies remain valuable tools in the neurologist's arsenal for the treatment of epilepsy.